Results 121 to 130 of about 11,769,643 (158)

Behavioral effects of α,α,β,β-tetradeutero-5-MeO-DMT in rats: comparison with 5-MeO-DMT administered in combination with a monoamine oxidase inhibitor [PDF]

Psychopharmacology, 2012
Ayahuasca is a psychoactive tea prepared from a combination of plants that contain a hallucinogenic tryptamine and monoamine oxidase inhibitors (MAOIs). Behavioral pattern monitor (BPM) experiments demonstrated that the combination of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) and a behaviorally inactive dose of an MAO(A) inhibitor such as harmaline ...
Adam L Halberstadt, Mark A. Geyer, David E. Nichols   +2 more
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Defining 5-MeO-DMT in Historical and Cultural Contexts

World Futures
Azul DelGrasso
exaly   +2 more sources

5-MeO-DMT

Abstract 5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is a psychoactive compound found in the parotid gland venom of the Sonoran Desert toad, Incilius alvarius, and certain seeds, leaves, and barks within the Amazonian rainforest. Similar to DMT containing ayahuasca, 5-MeO-DMT has become newly integrated as a spiritual sacrament in ...
Angelica Ukaigwe, Anjna Chauhan, Sameet Kumar   +2 more
openaire   +1 more source

Incilius alvarius cell-based synthesis of 5-MeO-DMT

2022
Abstract There is growing interest in the therapeutic potential of 5-MeO-DMT (5-methoxy-N,N-dimethyltryptamine) for psychiatric disorders. While 5-MeO-DMT can be chemically synthesized, the parotoid gland secretions of Incilius alvarius (also known as the Colorado River or Sonoran ...
Leonard Lerer, Eric Reynolds, Jeet Varia, Karin Blakolmer, Bernard Lerer   +4 more
openaire   +1 more source

The serotonergic hallucinogen 5-MeO-DMT disrupts cortical activity in rodents

European Neuropsychopharmacology, 2016
Trabajo presentado en el 29th ECNP Congress, celebrado en Viena, Austria, del 17 al 20 de septiembre de ...
Artigas, F.; Riga, M.; Celada, P.
openaire   +1 more source

Reply to: 5‐MeO‐DMT has not been found in traditional ayahuasca preparations and the combination of 5‐MeO‐DMT with MAOIs is dangerous

Human Psychopharmacology: Clinical and Experimental, 2022
Edward James, Joachim Keppler, Thomas L. Robertshaw, Ben Sessa   +3 more
openaire   +2 more sources

Examining the potential of psilocybin and 5-MeO-DMT as therapeutics for traumatic brain injury

Progress in Neuro-Psychopharmacology and Biological Psychiatry
Traumatic brain injury (TBI) is a significant global health challenge, with limited effective treatments for its acute and chronic consequences. TBI is characterized by neuroinflammation, oxidative stress, impaired neuroplasticity, imbalances in neurotransmission, and cell death - factors that contribute to the development of neurological and ...
Zoe, Plummer, Josh, Allen, Justin, Brand, Leah M, Mayo, Sandy R, Shultz, Brian R, Christie   +5 more
openaire   +2 more sources

5‐MeO‐DMT has not been found in traditional ayahuasca preparations and the combination of 5‐MeO‐DMT with MAOIs is dangerous

Human Psychopharmacology: Clinical and Experimental, 2022
openaire   +2 more sources

Fenomenologie 5-MeO-DMT a souvislost s aspekty duševního zdraví

2023
Given the increasing knowledge of psychedelic compounds in the field of mental health care provided by scientific research in recent decades, the aftereffects of 5-MeO-DMT on aspects of mental health are relatively unexplored. Its unique acute subjective effects can be observed within phenomenology.
openaire   +1 more source

CLINICAL CONSIDERATION OF 5-MeO-DMT

2019
Sherwood, Alexander M, Kaylo, Kristi W, Kargbo, Robert B, Davis, Alan K, Lancelotta, Rafael L, Uthaug, Malin V, Barrow, Robert B   +6 more
openaire   +1 more source